Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
MOSCOW, May 31, 2017 -- Atlant Clinical LLC will host two first MedDRA trainings in Russia. The trainings will take place at Atlant Clinical’s Moscow office on June 5-6, 2017 and will cover coding and safety data analysis as well as SMQs. Jane Knight, an experienced MSSO instructor, will lead both programs. The events will be free of charge for registered MedDRA users.
By hosting the event, Atlant confirms its leading position in the field of professional trainings for clinical research specialists. Being a MedDRA member, Atlant Clinical applies clinical trial and regulatory international dictionaries in its everyday work, which allows it to be fully compliant with major global standards.
Mikhail Groubman, CEO, said: “We are proud to become the host of the first MedDRA Trainings in Russia. Atlant Clinical supports the process of clinical data and medical terminology standards implementation. Unified international standards help to analyze, report, and submit clinical data in strict accordance with ICH GCP and regulatory requirements.
We constantly invest in our team, conducting regular internal trainings and ensuring its ongoing development and outstanding professionalism. We are happy to share such an opportunity not just with our employees but with more than 50 professionals throughout the country, who have already signed up for the trainings.”
About Atlant Clinical
Atlant Clinical is an international CRO, established in 2007, offering a full range of clinical trial and relevant support services throughout the US, Europe, Russia, and Middle Asia. Atlant Clinical has extensive clinical experience (Phases I–IV) in over 15 therapeutic areas. The team consists of over 150 experienced employees worldwide. Atlant Clinical has offices in Russia, the US, Germany, the UK, Lithuania, and Ukraine. The company’s clients range from some of the world's leading pharmaceutical companies to new and growing biotech firms.
Contact To learn more about the trainings or Atlant Clinical, please contact: Marietta Sarkisyan, Business Development Manager 76 N. Walnut Street Ridgewood, NJ 07450 Phone: +1 (201) 616 00 37 [email protected]
